ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.847,63
-0,52%
S&P 500
5.303,09
1,08%
US Dollar vs BRL
5,137
0,15%
Bitcoin
65.142,99
5,84%
Brent Oil
82,575
0,03%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Windtree Therapeutics Inc (WINT)

  7. Windtree Therapeutics Inc (WINT) Notícias

WINT

Windtree Therapeutics (WINT)

Windtree Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:WINT
DataHoraFonteTítuloCódigoCompanhia
09/05/202409:41Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:WINTWindtree Therapeutics Inc
07/05/202409:00GlobeNewswire Inc.Windtree Therapeutics Regains Compliance with NasdaqNASDAQ:WINTWindtree Therapeutics Inc
18/04/202409:00GlobeNewswire Inc.Windtree Therapeutics Announces Reverse Stock SplitNASDAQ:WINTWindtree Therapeutics Inc
17/04/202409:00GlobeNewswire Inc.Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business UpdatesNASDAQ:WINTWindtree Therapeutics Inc
08/04/202417:48GlobeNewswire Inc.Windtree Acquires Early-Stage, Novel Oncology Platform and Completes $1.5 Million Convertible Note Bridge FinancingNASDAQ:WINTWindtree Therapeutics Inc
16/02/202419:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:WINTWindtree Therapeutics Inc
14/02/202419:23Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:WINTWindtree Therapeutics Inc
14/02/202418:30Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:WINTWindtree Therapeutics Inc
12/02/202418:40Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:WINTWindtree Therapeutics Inc
01/02/202419:26Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:WINTWindtree Therapeutics Inc
01/02/202410:00GlobeNewswire Inc.Windtree Renews Agreement with Chang Gung University for Scientific Collaboration to Further SERCA2a ResearchNASDAQ:WINTWindtree Therapeutics Inc
31/01/202410:40InvestorsHub NewsWireWindtree Therapeutics Announces Engagement of Strategic Advisor to Support Assessment of Strategic AlternativesNASDAQ:WINTWindtree Therapeutics Inc
25/01/202411:04InvestorsHub NewsWireWindtree Eliminates $15 Million Contingent Liability to Deerfield Management CompanyNASDAQ:WINTWindtree Therapeutics Inc
17/01/202410:00GlobeNewswire Inc.Windtree Therapeutics Announces License Agreement with Lee’s Pharmaceuticals to Develop and Commercialize Istaroxime, Dual Mechanism SERCA2a Activators and Rostafuroxin for Greater China / Asia Pacific RegionNASDAQ:WINTWindtree Therapeutics Inc
16/01/202418:16Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:WINTWindtree Therapeutics Inc
02/01/202418:05GlobeNewswire Inc.Windtree Therapeutics Announces Reduction In Arrythmias In A New Study With Istaroxime And A Pure SERCA2a ActivatorNASDAQ:WINTWindtree Therapeutics Inc
18/12/202310:00GlobeNewswire Inc.Windtree Therapeutics Announces the Start of Patient Dosing In Phase 2 SEISMiC Extension Study of Istaroxime in Early Cardiogenic ShockNASDAQ:WINTWindtree Therapeutics Inc
16/11/202310:00GlobeNewswire Inc.Windtree Therapeutics Announces Issuance of New Pure SERCA2a Activator PatentNASDAQ:WINTWindtree Therapeutics Inc
09/11/202318:15GlobeNewswire Inc.Windtree Therapeutics Reports Third Quarter 2023 Financial Results and Provides Key Business UpdatesNASDAQ:WINTWindtree Therapeutics Inc
09/11/202318:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:WINTWindtree Therapeutics Inc
08/11/202310:00GlobeNewswire Inc.Windtree to Present at the Sidoti Micro Cap Conference on November 16thNASDAQ:WINTWindtree Therapeutics Inc
12/10/202308:30GlobeNewswire Inc.Windtree to Present at the ThinkEquity Conference on October 19th in New York CityNASDAQ:WINTWindtree Therapeutics Inc
10/10/202308:30GlobeNewswire Inc.Windtree to Participate in the Lytham Partners Fall 2023 Investor Conference on October 17thNASDAQ:WINTWindtree Therapeutics Inc
03/10/202309:00GlobeNewswire Inc.Windtree to Present at the Dawson James Small Cap Growth Conference on October 12thNASDAQ:WINTWindtree Therapeutics Inc
28/09/202308:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WINTWindtree Therapeutics Inc
21/09/202310:35GlobeNewswire Inc.Dawson James Securities Announces October Date for 8th Annual Small Cap Growth ConferenceNASDAQ:WINTWindtree Therapeutics Inc
05/09/202320:21Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:WINTWindtree Therapeutics Inc
30/08/202317:31Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:WINTWindtree Therapeutics Inc
23/08/202309:00GlobeNewswire Inc.Windtree Announces Issuance of Composition of Matter Patent for Dual Mechanism SERCA2a Activators by the US Patent and Trademark OfficeNASDAQ:WINTWindtree Therapeutics Inc
07/08/202317:05GlobeNewswire Inc.Windtree Therapeutics Reports Second Quarter 2023 Financial Results and Provides Key Business UpdatesNASDAQ:WINTWindtree Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:WINT

Seu Histórico Recente

NYSE
VLT
Invesco High Income Trus...
BIT
UC7PXH
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados